The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: MD Primer Inc.

Monday Biotech Deal Review: January 3, 2011

Happy New Year, and welcome to the first Monday Biotech Deal Review of 2011!  There were only a handful of items to report on from last week, as the holiday season brought the usual corporate slow-down.  Nevertheless, the week saw the completion of a couple of private placements (CardioComm and Ondine Biomedical), along with the expansion of the previously announced Theralase private placement.  Read on to learn more.   Read more of this post

Monday Biotech “Happy Holidays” Deal Review: December 27, 2010

Welcome to your Monday Biotech “Happy Holidays” Deal Review!  For those who may have noticed, last week the Monday Biotech Deal Review took its own holiday, so this week’s digest contains biotech news spanning the past two weeks – to ensure you don’t miss a single drummer boy’s beat.  It has been a busy two weeks, with a notable $40M public offering by YM BioSciences of common shares that was announced, priced and closed, as well as an update by Angiotech with respect to its debt restructuring efforts.  There have also been some interesting strategic partnerships and licensing activity over the break.  Read on to learn more.     Read more of this post

Follow

Get every new post delivered to your Inbox.

Join 129 other followers